HER2-Targeted Antibody-Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget's Disease Models: In Vivo and Immunohistochemical Analyses.
Cancers (Basel). 2022 Jul 20;14(14):3519. doi: 10.3390/cancers14143519.
Cancers (Basel). 2022.
PMID: 35884581
Free PMC article.